$ACUR consolidation Pr $0.79 After hours The
Post# of 16
Posted On: 05/04/2015 8:34:02 PM
$ACUR consolidation Pr $0.79
After hours
The Company reported net income of $1.2 million for the first quarter 2015 or $0.03 per diluted share, compared to net loss of $4.1 million or $0.08 per diluted share for the same period in 2014.
Revenues for the quarter were $5.4 million compared to only $42 thousand in the first quarter of 2014 reflecting the $5.0 million payment arising from licensing Oxaydo to Egalet Corporation entities.
Shares Outstanding: 48.95M
Float: 23.78M
% Held by Insiders: 34.52%
% Held by Institutions: 24.90%
Shares Short (as of Mar 31, 2015): 56.81K
Short Ratio (as of Mar 31, 2015): 0.40
Short % of Float (as of Mar 31, 2015): 0.20%
Shares Short (prior month): 56.38K
headlines
After hours
The Company reported net income of $1.2 million for the first quarter 2015 or $0.03 per diluted share, compared to net loss of $4.1 million or $0.08 per diluted share for the same period in 2014.
Revenues for the quarter were $5.4 million compared to only $42 thousand in the first quarter of 2014 reflecting the $5.0 million payment arising from licensing Oxaydo to Egalet Corporation entities.
Shares Outstanding: 48.95M
Float: 23.78M
% Held by Insiders: 34.52%
% Held by Institutions: 24.90%
Shares Short (as of Mar 31, 2015): 56.81K
Short Ratio (as of Mar 31, 2015): 0.40
Short % of Float (as of Mar 31, 2015): 0.20%
Shares Short (prior month): 56.38K
headlines
(0)
(0)Acura Pharmaceuticals Inc. (ACUR) Stock Research Links
Scroll down for more posts ▼